Crossmark

Patient- and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study)

Crossref DOI link: https://doi.org/10.1016/j.ad.2026.104632

Published Print: 2026-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gilaberte, Y.

Yélamos, O.

Cañueto, J.

Serra-Guillén, C.

Conti, A.

Pajuelo, F.

Lecchi, A.

Cappello, V.

Kostov, B.

Padullés, L.

Romanelli, M.
Funding

Funding for this research was provided by:

Almirall SA
License Information

Text and Data Mining valid from 2026-07-01

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-03-17
More Information

This article is maintained by: Elsevier

Article Title: Patient- and Clinician-reported Outcomes, Safety and Efficacy Profile of Tirbanibulin 1% for Actinic Keratosis Under Conditions Close to Routine Clinical Practice in Spain and Italy (TIRBASKIN Study)

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2026.104632

Content Type: article

Copyright: © 2026 AEDV. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below